CAS 326816-37-9

Fórmula: C8H9Cl2F3N2

InChI: InChI=1S/C8H8ClF3N2.ClH/c9-6-3-5(8(10,11)12)4-14-7(6)1-2-13;/h3-4H,1-2,13H2;1H

Chave InChI: XZPAHUSHYKUMPU-UHFFFAOYSA-N

SMILES: C1=C(C=NC(=C1Cl)CCN)C(F)(F)F.Cl

2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]ethylamine hydrochloride

CAS: 326816-37-9

2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]ethylamine hydrochloride

Fórmula: C₈H₈ClF₃N₂·ClH

Pureza: 95%

Peso molecular: 261.07166

Ref: 54-PC446176

2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]ethanamine hydrochloride

CAS: 326816-37-9

Fórmula: C₈H₉Cl₂F₃N₂

Pureza: 98%

Cor e Forma: Solid

Peso molecular: 261.0717

Ref: IN-DA01FQ0E

2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]ethan-1-amine hydrochloride

CAS: 326816-37-9

2-[3-Chloro-5-(trifluoromethyl)pyridin-2-yl]ethan-1-amine hydrochloride (2CFPE) is a dpp-IV inhibitor. It inhibits the enzyme dipeptidyl peptidase IV, which is responsible for the degradation of the incretin hormone glucagon-like peptide 1 (GLP1). 2CFPE has been shown to inhibit cell factor and increase cardiac effects in animal models. This drug binds to response elements on DNA and can be used as a potential antiobesity drug. 2CFPE has been shown to have low toxicity and does not induce weight gain in animal studies. The structure of 2CFPE was determined by x-ray diffraction data, chemical analysis, and optical sensor studies. The mechanism of action for 2CFPE involves benzalkonium chloride binding to GLP1R and activating it, leading to

Fórmula: C₈H₈ClF₃N₂•HCl

Pureza: Min. 95%

Cor e Forma: Powder

Peso molecular: 261.07 g/mol

Ref: 3D-BNA81637